Pediatric sepsis and multiple organ dysfunction syndrome

被引:45
作者
Despond, O
Proulx, F
Carcillo, JA
Lacroix, J
机构
[1] Univ Montreal, Hop St Justine, Dept Pediat, Div Pediat Intens Care, Montreal, PQ H3T 1C5, Canada
[2] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA
[3] Dept Anesthesiol, Div Crit Care Med, Pittsburgh, PA USA
关键词
D O I
10.1097/00008480-200106000-00006
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Systemic inflammatory response syndrome may be viewed as the systemic expression of cytokine signals that normally function on an autocrine or paracrine level. Sepsis is defined as systemic inflammatory response syndrome caused by an infection. Multiple organ dysfunction syndrome may represent the end stage of severe systemic inflammatory response syndrome or sepsis. Many cells are involved, including endothelial cells and leukocytes and multiple proinflammatory and antiinflammatory mediators (cytokines, oxygen free radicals, coagulation factors; and so forth), Various pathophysiologic mechanisms have been postulated. The most popular theorys that the inflammatory process loses its autoregulatory capacity; however, microcirculatory dysregulation and apoptosis may also be important, and a new paradigm posits a complex nonlinear system. Many new treatments have been studied recently. The usefulness of immune modulating diets remains to be evaluated, Molecular immunomodulation is still of unclear value. The therapy of sepsis:and multiple organ dysfunction syndrome remains mainly supportive. Curr Opin Pediatr 2001 13:247-253 (C) 2001 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码:247 / 253
页数:7
相关论文
共 68 条
  • [1] Tissue factor inhibition and clinical trial results of tissue factor pathway inhibitor in sepsis - Question and answer session after scientific review
    Vincent, JL
    Abraham, E
    Esmon, C
    Hack, CE
    [J]. CRITICAL CARE MEDICINE, 2000, 28 (09) : S33 - S33
  • [2] ALEJANDRIA MM, 2000, COCHRANE LIB, P1
  • [3] Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome
    Angstwurm, MWA
    Schottdorf, J
    Schopohl, J
    Gaertner, R
    [J]. CRITICAL CARE MEDICINE, 1999, 27 (09) : 1807 - 1813
  • [4] Inappropriate sympathetic activation at onset of septic shock - A spectral analysis approach
    Annane, D
    Trabold, F
    Sharshar, T
    Jarrin, I
    Blanc, AS
    Raphael, JC
    Gajdos, P
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (02) : 458 - 465
  • [5] [Anonymous], 1991, REP COMM INF DIS
  • [6] Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients
    Aouifi, A
    Piriou, V
    Bastien, O
    Blanc, P
    Bouvier, H
    Evans, R
    Célard, M
    Vandenesch, F
    Rousson, R
    Lehot, JJ
    [J]. CRITICAL CARE MEDICINE, 2000, 28 (09) : 3171 - 3176
  • [7] A prospective, randomized, double-blind, controlled clinical trial of enteral immunonutrition in the critically ill
    Atkinson, S
    Sieffert, E
    Bihari, D
    [J]. CRITICAL CARE MEDICINE, 1998, 26 (07) : 1164 - 1172
  • [8] Nitric oxide production in meningococcal disease is directly related to disease severity
    Baines, PB
    Stanford, S
    Bishop-Bailey, D
    Sills, JA
    Thomson, APJ
    Mitchell, JA
    Fear, SC
    Hart, CA
    Petros, AJ
    [J]. CRITICAL CARE MEDICINE, 1999, 27 (06) : 1187 - 1190
  • [9] Immunonutrition comes of age
    Barbul, A
    [J]. CRITICAL CARE MEDICINE, 2000, 28 (03) : 884 - 885
  • [10] Immunonutrition in the critically ill: A systematic review of clinical outcome
    Beale, RJ
    Bryg, DJ
    Bihari, DJ
    [J]. CRITICAL CARE MEDICINE, 1999, 27 (12) : 2799 - 2805